article thumbnail

National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them

Fierce Pharma

The National Comprehensive Cancer Network's recent survey shows that nearly all of the treatment centers it polled are facing a carboplatin shortage. As pharma supply chain problems drag on, a shortage of key cancer drugs has afflicted a large number of treatment centers and many patients. |

article thumbnail

Streamlining Center of Excellence Provider Network Development in Record Time

Clarify Health

CoEs can be established by a variety of entities, including healthcare organizations, medical institutions, government agencies, and sometimes private entities. Behind the benefits administrator’s comprehensive CoE experience for each patient is extensive research to identify and understand the clinical quality of providers in their network.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What if Bill Clinton & Ronald Reagan Had Debates Universal Government Funded Healthcare? A Fictional Debate Portrayal.

Pharma Marketing Network

Bill Clinton: My fellow Americans, I stand here today to argue in favor of universal government-funded healthcare. Furthermore, universal government-funded healthcare would help to level the playing field for all Americans, regardless of their socioeconomic status. appeared first on Pharma Marketing Network.

article thumbnail

Crossing the Interoperability Finish Line: Will TEFCA Help?

MedCity News

TEFCA’s goal is to establish a universal floor for interoperability across the country by developing the infrastructure model and governing approach for users in different networks to securely share basic clinical information with each other.

article thumbnail

Webinar recap: How Cigna is Innovating their Network Design Process

Clarify Health

On December 16th, we hosted an AHIP webinar discussion about how Cigna is innovating their network design process for market expansion. Austin has spent the last eight years at Cigna with responsibility for medical economics and analytics, leading the transformation of data and analytics for their government business segment.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance.

article thumbnail

Sustainability - at the heart of what we do

PharmaTech

Across our network of companies globally and regionally in North America, Eurofins has made a significant amount of progress related to our Environmental, Social and Governance initiatives. At Eurofins, we believe that sustainability is at the heart of what we do.